Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01375842
Title A Phase 1 Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

Atezolizumab

Age Groups: adult
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
HonorHealth Research Institute - Pima Center Scottsdale Arizona 85258 United States Details
The Angeles Clinic Los Angeles California 90025 United States Details
Stanford Univ Medical Center; Dept Central Pharmacy Stanford California 94305 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Moffitt Cancer Center Tampa Florida 33647 United States Details
Uni of Chicago Chicago Illinois 60637 United States Details
Johns Hopkins Univ Med Center Baltimore Maryland 21231 United States Details
Massachusetts General Hospital. Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Med Ctr Boston Massachusetts 02215 United States Details
Dana Farber Can Ins Boston Massachusetts 02215 United States Details
Comprehensive Cancer Centers of Nevada - Eastern Avenue Las Vegas Nevada 89169 United States Details
New York Oncology Hematology, P.C. Albany New York 12206 United States Details
Carolina BioOncology Institute; Can Therapy & Res Ctr Huntersville North Carolina 28078 United States Details
Sarah Cannon Research Inst. Nashville Tennessee 37203 United States Details
Vanderbilt Nashville Tennessee 37232 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Centre Leon Berard Lyon 69008 France Details
Institut Claudius Regaud; Departement Oncologie Medicale Toulouse 31059 France Details
Institut Gustave Roussy; Drct Villejuif 94805 France Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Barts & London School of Med; Medical Oncology London EC1A 7BE United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field